- bluebird bio Reports First Quarter 2024 Results and Highlights Operational Progress and 2024 Guidance
- bluebird bio Announces First Quarter 2024 Results Call Date and Upcoming Investor Events
- bluebird bio Announces Completion of First Cell Collection for LYFGENIA™ Gene Therapy
- bluebird bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- bluebird bio Reports Fourth Quarter and 2023 Annual Results and Highlights Operational Progress and 2024 Guidance
- bluebird bio to Host Fourth Quarter and 2023 Annual Results Conference Call
- bluebird bio Secures up to $175 Million Debt Financing with Hercules Capital
- bluebird bio Announces First Outcomes-Based Agreement with Medicaid for Sickle Cell Disease Gene Therapy
More ▼
Key statistics
On Friday, bluebird bio Inc (BLUE:NSQ) closed at 1.03, 21.03% above the 52 week low of 0.851 set on May 06, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.03 |
---|---|
High | 1.06 |
Low | 1.02 |
Bid | 1.03 |
Offer | 1.06 |
Previous close | 1.05 |
Average volume | 7.11m |
---|---|
Shares outstanding | 190.36m |
Free float | 189.64m |
P/E (TTM) | -- |
Market cap | 194.16m USD |
EPS (TTM) | -0.7446 USD |
Data delayed at least 15 minutes, as of May 17 2024 21:00 BST.
More ▼